Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 615,756 |
|
|||||
| News | - | ||||||
| Day High | 901.065 | Low High |
|||||
| Day Low | 890.43 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc | REGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -4.42 | -0.49% | 894.14 | 18:01:19 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 897.22 | 890.43 | 901.065 | 894.14 | 898.56 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 19,057 | 615,756 | $ 895.35 | $ 551,317,172 | - | 684.805 - 998.325 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:23:30 | 2 | $ 894.15 | USD |
Regeneron Pharmaceuticals (REGN) Options Flow Summary
Regeneron Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 98.14B | 109.76M | - | 13.12B | 3.95B | 36.02 | 24.82 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Regeneron Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical REGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 941.39 | 949.195 | 890.43 | 916.00 | 525,945 | -47.25 | -5.02% |
| 1 Month | 965.11 | 979.255 | 890.43 | 944.44 | 424,443 | -70.97 | -7.35% |
| 3 Months | 945.11 | 998.325 | 890.43 | 954.30 | 465,531 | -50.97 | -5.39% |
| 6 Months | 842.81 | 998.325 | 769.19 | 892.93 | 515,300 | 51.33 | 6.09% |
| 1 Year | 833.00 | 998.325 | 684.805 | 830.78 | 529,302 | 61.14 | 7.34% |
| 3 Years | 496.6488 | 998.325 | 478.40 | 695.25 | 652,693 | 397.49 | 80.03% |
| 5 Years | 377.90 | 998.325 | 271.37 | 579.54 | 775,325 | 516.24 | 136.61% |
Regeneron Pharmaceuticals Description
| Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently. |
